Q Biomed Inc. Modifies Over 3.6 Million Warrants, Reclassifies Equity to Liability
Track all markets on TradingView Q Biomed Inc. (QBIO), a biomedical acceleration and development company, updated its financial records to include the modification of an aggregate of 3,608,641 warrants originally granted to certain officers during 2017 and 2021. The exercise price of the warrants was reduced to $0.10 per share, resulting in an immediate recognition […]
Q Biomed Inc. Modifies Over 3.6 Million Warrants, Reclassifies Equity to Liability Read More »